SCHEMBL2992933

SCHEMBL2992933

C=C(C)C(=O)OC1CCCCCC1(C(=O)O)C(=O)O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.33
MAPT P10636 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1109617 1.00 CYP2C19 (0.33) CYP2C19MAPTALDH1A1
SCHEMBL23493906 0.79 ALDH1A1 (0.33) CYP2C19MAPTALDH1A1
SCHEMBL18051634 0.78 MAPT (0.36) CYP2C19MAPTALDH1A1
SCHEMBL31279952 0.76 ALDH1A1 (0.31) ALDH1A1
SCHEMBL967974 0.72 ALDH1A1 (0.33) ALDH1A1
SCHEMBL14814646 0.71
SCHEMBL14814869 0.71
Bicarbonate SCHEMBL13570854 0.71 EPHX1 (0.43) CYP2C19ALDH1A1
SCHEMBL17812574 0.70 CYP2C19 (0.33) CYP2C19
SCHEMBL22480 0.70 EPHX1 (0.46) CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165759-A1 DENTAL CURABLE COMPOSITION TOKUYAMA DENTAL CORPORATION (JP) 2023-06-01 US disclosed
EP-4166127-A1 DENTAL CURABLE COMPOSITION Tokuyama Dental Corporation (JP) 2023-04-19 EP disclosed
EP-2548916-B2 ORGANIC/INORGANIC COMPOSITE FILLER AND MANUFACTURING METHOD THEREFOR TOKUYAMA DENTAL CORP (JP) 2023-03-22 EP disclosed
US-11001713-B2 Organic/inorganic composite filler and manufacturing method therefor TOKUYAMA DENTAL CORPORATION (JP) 2021-05-11 US disclosed
US-20180273766-A1 Organic/Inorganic Composite Filler and Manufacturing Method Therefor TOKUYAMA DENTAL CORPORATION (JP) 2018-09-27 US disclosed
EP-2724706-B1 DENTAL RESTORATIVE MATERIAL TOKUYAMA DENTAL CORP (JP) 2018-09-12 EP disclosed
US-10005910-B2 Organic/inorganic composite filler and manufacturing method therefor TOKUYAMA DENTAL CORPORATION (JP) 2018-06-26 US disclosed
EP-2757112-B1 ORGANIC-INORGANIC COMPOSITE FILLER, AND METHOD FOR PRODUCING SAME TOKUYAMA DENTAL CORP (JP) 2017-02-22 EP disclosed
EP-2548916-B1 ORGANIC/INORGANIC COMPOSITE FILLER AND MANUFACTURING METHOD THEREFOR TOKUYAMA DENTAL CORP (JP) 2016-12-28 EP disclosed
US-9320684-B2 Dental restorative material TOKUYAMA DENTAL CORPORATION (JP) 2016-04-26 US disclosed
US-20040048948-A1 Adhesive composition for denture base relining material and dental curable composition TOKUYAMA DENTAL CORPORATION (JP) 2004-03-11 US disclosed
EP-1348416-A1 ADHESIVE COMPOSITIONS FOR BACK-COATING DENTAL PLATE AND HARDENING COMPOSITIONS FOR DENTAL USE TOKUYAMA CORPORATION (JP) 2003-10-01 EP disclosed
US-20030162863-A1 Photo-curable reparative material for dental use TOKUYAMA CORPORATION (JP) 2003-08-28 US disclosed
US-20030036582-A1 Dental curable composition TOKUYAMA CORPORATION (JP) 2003-02-20 US disclosed
EP-1236459-A1 PHOTO-CURABLE REPARATIVE MATERIAL FOR DENTAL USE TOKUYAMA CORPORATION (JP) 2002-09-04 EP disclosed
EP-1226807-A1 DENTAL CURABLE COMPOSITION TOKUYAMA CORPORATION (JP) 2002-07-31 EP disclosed
US-5856374-A IRREGULARLY-SHAPED, SPHERICAL AND FINE INORGANIC PARTICLE FILLERS TOKUYAMA CORPORATION (JP) 1999-01-05 US disclosed
EP-0839511-A2 Curable composition TOKUYAMA CORPORATION (JP) 1998-05-06 EP disclosed
US-5260476-A Dental restoration TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1993-11-09 US disclosed
US-5171763-A A dental composite of a monomer containing poly(3,4-carboxylic benzoic acid and acrylic ester moities, an ion leachable filler and an initiator; high adhesion and strength; discoloration inhibition TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1992-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005910-B2 Organic/inorganic composite filler and manufacturing method therefor VCL, PIEZO1, ORAI1 CYP2C19 3018/4885MAPT 1694/4885ALDH1A1 2597/4885
US-20180273766-A1 Organic/Inorganic Composite Filler and Manufacturing Method Therefor VCL, PIEZO1, ORAI1 CYP2C19 3018/4885MAPT 1694/4885ALDH1A1 2597/4885
US-20030162863-A1 Photo-curable reparative material for dental use MBTD1, AP3M1, MYO1G CYP2C19 4360/4885MAPT 3369/4885ALDH1A1 1806/4885
US-20040048948-A1 Adhesive composition for denture base relining material and dental curable composition TAS2R42, TAF1, CAD CYP2C19 2639/4885MAPT 1021/4885ALDH1A1 104/4885
US-11001713-B2 Organic/inorganic composite filler and manufacturing method therefor VCL, PIEZO1, ORAI1 CYP2C19 3018/4885MAPT 1694/4885ALDH1A1 2597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.